Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]
This entry reports a planned Phase 1/Phase 2 clinical trial evaluating abemaciclib in combination with bicalutamide for androgen receptor-po…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) [Phase 2]
This Phase 2 MATCH Screening Trial update describes ongoing evaluation of targeted therapies matched to genetic alterations in patients with…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]
This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
A Pfizer-sponsored real-world study is evaluating first-line palbociclib with endocrine therapy for HR+/HER2- advanced breast cancer; the tr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer [NA]
Clinical trial update describing an educational video intervention to improve patient understanding of tumor genomic testing in metastatic c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of entinostat, nivolumab, and ipilimumab in patients with metastatic or inoperable HER2-ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Assessment of the Interi Manifold in Implant-Based Breast Reconstruction [NA]
This ClinicalTrials.gov entry indicates the Interi Manifold study for implant-based breast reconstruction is currently recruiting at Stanfor…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors [NA]
Clinical trial evaluating Baduanjin exercise to improve upper limb dysfunction in breast cancer survivors. The study status is not yet recru…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: FAP PET/CT for Staging Patients With Breast Cancer [Phase 2]
A Phase 2 clinical trial is exploring FAP PET/CT imaging to stage patients with breast cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Peer Support For Young Adult Women With High Breast Cancer Risk [NA]
Georgetown University is conducting a clinical trial on peer support for young adult women at high risk of breast cancer, and the study is c…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of cyclophosphamide and veliparib for locally advanced or metastatic breast cancer; the st…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Who Achieved Durable Response by Anti-HER2 Treatment (HER2 CR)
Clinical trial update describing ctDNA-based personalized detection for patients with HER2-positive metastatic breast cancer who achieved du…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
A clinical trial update describes ongoing evaluation of evidence-based chemotherapy use in endocrine-sensitive breast cancer. The study is c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer [Phase 1]
A Phase 1 clinical trial update indicates Boundless Bio is recruiting participants for BBI-940, an oral kinesin degrader, in advanced or met…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Biomarkers to Detect Endocrine Therapy Resistance [Phase 2]
A Phase 2 clinical trial update focused on identifying biomarkers to detect resistance to endocrine therapy in metastatic breast cancer, inc…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase IIa Study to Evaluate NBQ72S [Phase 2]
A Phase IIa study to evaluate NBQ72S in breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of HLD-0117 in Patients With Metastatic Breast Cancer [Phase 1]
This clinical trial update indicates that a Phase 1 study of HLD-0117 for metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer [NA]
A clinical trial is evaluating spa therapy to assess its potential benefit on radiation-induced fibrosis in patients with breast cancer or h…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ribociclib for HR-positive, HER2-negative metastatic breast cancer is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Oral Aromatase Inhibitors Modify the Gut Microbiome
A clinical trial is recruiting to study whether oral aromatase inhibitors affect the gut microbiome in breast cancer patients.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. [Phase 1]
This is a first-in-human Phase 1 clinical trial to assess the safety of ES2B-C001-S01 (with or without adjuvant) in patients with HER2-expre…
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Managed Access Programs for LEE011, Ribociclib
Clinical trial update announcing managed access programs for ribociclib (LEE011) in breast cancer.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies [Phase 2]
A Phase 2 trial update from UNC Lineberger Comprehensive Cancer Center for biomarker-driven therapies in breast cancer, currently recruiting…